Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2017 Jan;69(1):117-128.
doi: 10.1053/j.ajkd.2016.07.031. Epub 2016 Sep 29.

Sleep Disorders, Restless Legs Syndrome, and Uremic Pruritus: Diagnosis and Treatment of Common Symptoms in Dialysis Patients

Affiliations
Review

Sleep Disorders, Restless Legs Syndrome, and Uremic Pruritus: Diagnosis and Treatment of Common Symptoms in Dialysis Patients

Jennifer S Scherer et al. Am J Kidney Dis. 2017 Jan.

Abstract

Maintenance dialysis patients experience a high burden of physical and emotional symptoms that directly affect their quality of life and health care utilization. In this review, we specifically highlight common troublesome symptoms affecting dialysis patients: insomnia, restless legs syndrome, and uremic pruritus. Epidemiology, pathophysiology, and evidence-based current treatment are reviewed with the goal of providing a guide for diagnosis and treatment. Finally, we identify multiple additional areas of further study needed to improve symptom management in dialysis patients.

Keywords: Sleep disorders; chronic renal failure; dialysis; end-stage renal disease (ESRD); insomnia; kidney disease; quality of life (QoL); restless legs syndrome; review; symptom management; symptoms; uremic pruritus.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Approach to diagnosis and management of restless legs syndrome (RLS). *Drugs should be used with careful monitoring for signs of augmentation, as described in text. Drug treatment recommendations based on Molnar et al.
Figure 2
Figure 2
Management of pruritus in patients with chronic kidney disease.–,–,,–,, BUN, blood urea nitrogen; GFR, glomerular filtration rate; PTH, parathyroid hormone; UP, uremic pruritus.

References

    1. Abdel-Kader K, Unruh ML, Weisbord SD. Symptom burden, depression, and quality of life in chronic and end-stage kidney disease. Clin J Am Soc Nephrol. 2009;4:1057–1064. - PMC - PubMed
    1. Murtagh FE, Addington-Hall J, Higginson IJ. The prevalence of symptoms in end-stage renal disease: a systematic review. Adv Chronic Kidney Dis. 2007;14:82–99. - PubMed
    1. Davison SN, Jhangri GS. Impact of pain and symptom burden on the health-related quality of life of hemodialysis patients. J Pain Symptom Manage. 2010;39:477–485. - PubMed
    1. Lowney AC, Myles HT, Bristowe K, et al. Understanding what influences the health-related quality of life of hemodialysis patients: a collaborative study in England and Ireland. J Pain Symptom Manage. 2015;50:778–785. - PubMed
    1. Claxton RN, Blackhall L, Weisbord SD, Holley JL. Undertreatment of symptoms in patients on maintenance hemo-dialysis. J Pain Symptom Manage. 2010;39:211–218. - PubMed